Cingoranelli et al., 2023 - Google Patents
The Production of Therapeutic RadionuclidesCingoranelli et al., 2023
- Document ID
- 1738972439667015869
- Author
- Cingoranelli S
- Lapi S
- Publication year
- Publication venue
- Radiopharmaceutical Therapy
External Links
Snippet
Most medicinal radionuclides are not naturally occurring and must therefore be produced via nuclear reactions. An understanding of both nuclear reactions and the decay properties of radionuclides can guide the methods for the production of these important tools. Nuclear …
- 238000004519 manufacturing process 0 title abstract description 115
Classifications
-
- G—PHYSICS
- G21—NUCLEAR PHYSICS; NUCLEAR ENGINEERING
- G21G—CONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
- G21G1/00—Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes
- G21G1/04—Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes outside nuclear reactors or particle accelerators
- G21G1/10—Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes outside nuclear reactors or particle accelerators by bombardment with electrically charged particles
-
- G—PHYSICS
- G21—NUCLEAR PHYSICS; NUCLEAR ENGINEERING
- G21G—CONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
- G21G1/00—Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes
- G21G1/04—Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes outside nuclear reactors or particle accelerators
- G21G1/06—Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes outside nuclear reactors or particle accelerators by neutron irradiation
-
- G—PHYSICS
- G21—NUCLEAR PHYSICS; NUCLEAR ENGINEERING
- G21G—CONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
- G21G1/00—Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes
- G21G1/001—Recovery of specific isotopes from irradiated targets
- G21G2001/0042—Technetium
-
- G—PHYSICS
- G21—NUCLEAR PHYSICS; NUCLEAR ENGINEERING
- G21G—CONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
- G21G1/00—Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes
- G21G1/0005—Isotope delivery systems
-
- G—PHYSICS
- G21—NUCLEAR PHYSICS; NUCLEAR ENGINEERING
- G21G—CONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
- G21G4/00—Radioactive sources
- G21G4/04—Radioactive sources other than neutron sources
- G21G4/06—Radioactive sources other than neutron sources characterised by constructional features
-
- G—PHYSICS
- G21—NUCLEAR PHYSICS; NUCLEAR ENGINEERING
- G21G—CONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
- G21G4/00—Radioactive sources
- G21G4/02—Neutron sources
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Radchenko et al. | Production and supply of α-particle–emitting radionuclides for targeted α-therapy | |
| EP0990238B1 (en) | Neutron-driven element transmutation | |
| Beyer et al. | Production routes of the alpha emitting 149Tb for medical application | |
| Qaim | Medical radionuclide production: science and technology | |
| Srivastava et al. | Therapeutic radionuclides: production, physical characteristics, and applications | |
| Sadeghi et al. | Accelerator production of the positron emitter zirconium-89 | |
| Nawar et al. | New strategies for a sustainable 99mTc supply to meet increasing medical demands: Promising solutions for current problems | |
| Maiti et al. | Investigation on the production and isolation of 149,150,151 Tb from 12C irradiated natural praseodymium target | |
| Moody | Synthesis of superheavy elements | |
| Pupillo et al. | Nuclear data for light charged particle induced production of emerging medical radionuclides | |
| Friend et al. | Production of 230Pa by proton irradiation of 232Th at the LANL isotope production facility: precursor of 230U for targeted alpha therapy | |
| Kazakov et al. | Photonuclear production of medical radiometals: A review of experimental studies | |
| Alliot et al. | Is there an interest to use deuteron beams to produce non-conventional radionuclides? | |
| Khandaker et al. | Production cross-sections for the residual radionuclides from the natCd (p, x) nuclear processes | |
| Grundler et al. | The metamorphosis of radionuclide production and development at Paul Scherrer Institute | |
| Thisgaard et al. | Production of the Auger emitter 119Sb for targeted radionuclide therapy using a small PET-cyclotron | |
| Khandaker et al. | Excitation functions of proton induced nuclear reactions on natW up to 40áMeV | |
| Kazakov et al. | Production of 177 Lu by hafnium irradiation using 55-MeV bremsstrahlung photons | |
| Minato et al. | Measurement and Estimation of the 99Mo Production Yield by 100Mo (n, 2 n) 99Mo | |
| Radford et al. | Methods for the Production of Radionuclides for Medicine | |
| Kin et al. | Production of high-purity medical radio isotope 64Cu with accelerator-based neutrons generated with 9 and 12 MeV deuterons | |
| Nagai | Production scheme for diagnostic-therapeutic radioisotopes by accelerator neutrons | |
| Cingoranelli et al. | The Production of Therapeutic Radionuclides | |
| Zandi et al. | Evaluation of the cyclotron production of 165 Er by different reactions | |
| Pang et al. | Progress of photonuclear cross sections for medical radioisotope production at the SLEGS energy domain |